GLX Analytix

Neurovision

This company provides diagnostic blood tests and retinal imaging software to help healthcare providers detect and monitor neurodegenerative diseases.

Pre Diagnostics

This company develops intracellular blood tests and biomarker analytical services for the early detection of Alzheimer's disease for patients, practitioners and researchers.

neuroClues

This company develops portable eye-tracking medical devices and AI software for clinicians to identify neurological disorders through ocular biomarkers.

Neuraworx

This company develops a wearable neurostimulation device that enhances the brain's waste clearance system to treat neurodegenerative diseases and traumatic brain injuries.

InterVenn BioSciences

This company develops glycoproteomic diagnostic tests and an AI-driven analysis platform for clinicians and biopharmaceutical partners to improve disease detection and treatment.

Cytox

This company develops non-invasive genetic tests for Alzheimer's disease risk assessment and patient stratification for clinicians and pharmaceutical researchers.

Hemispheric

This company develops artificial intelligence models and platforms for decoding non-invasive brain signals to assist clinicians and researchers with neurological and psychiatric diagnoses.

Neuronostics

The company develops an EEG-based digital biomarker platform to provide objective diagnostic and prognostic support for epilepsy to healthcare providers and pharmaceutical researchers.